APA (7th ed.) Citation

H, S., DM, K., E, L., JK, D., M, B., ZN, S., . . . C, K. (2025). Characterization of 223 infants with CFTR-related metabolic syndrome/Cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 24(2), 404. https://doi.org/10.1016/j.jcf.2024.10.015

Chicago Style (17th ed.) Citation

H, Sadeghi, et al. "Characterization of 223 Infants with CFTR-related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID) Identified During the First Three Years of Newborn Screening via IRT-DNA-SEQ in New York State." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 24, no. 2 (2025): 404. https://doi.org/10.1016/j.jcf.2024.10.015.

MLA (9th ed.) Citation

H, Sadeghi, et al. "Characterization of 223 Infants with CFTR-related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID) Identified During the First Three Years of Newborn Screening via IRT-DNA-SEQ in New York State." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 24, no. 2, 2025, p. 404, https://doi.org/10.1016/j.jcf.2024.10.015.